The Role of Lung Ultrasound in The Diagnosis of Weaning -Induced Pulmonary Edema
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The aim of the work is to
- 1.Assess the incidence of weaning induced pulmonary adema(WIPO).
- 2.Assess the risk factors of WIPO.
- 3.Evaluate the role of lung ultrasound in detecting WIPO during spontenous breathing trial(SBT).
- 4.Detect the threshold of B-line increase (Delta-B-lines) that provided the best diagnostic accuracy of WIPO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2020
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
July 5, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedJuly 9, 2020
July 1, 2020
5 months
July 5, 2020
July 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the number of B-lines in lung ultrasound and its accuracy in diagnosis of weaning induced pulmonary oedema
1 year
Study Arms (2)
group 1
patient who will develop weaning induced pulmonary adema
group 2
patient who will nor develop weaning induced pulmonary adema
Interventions
Eligibility Criteria
The study will include patients on mechanical ventilation who will be suitable for spontaneous breathing trial (SBT).
You may qualify if:
- The study will include patients on mechanical ventilation who will be suitable for spontaneous breathing trial (SBT).
You may not qualify if:
- Patients with poor lung ultrasound window, history of cardiomyopathy, significant valvular disease (aortic or mitral insufficiency of grade ≥ 2, mild or severe aortic and mitral stenosis) will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Internal Medicine
Study Record Dates
First Submitted
July 5, 2020
First Posted
July 9, 2020
Study Start
July 1, 2020
Primary Completion
December 1, 2020
Study Completion
July 1, 2021
Last Updated
July 9, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share